Nardone, Agostina
Weir, Hazel
Delpuech, Oona
Brown, Henry
De Angelis, Carmine
Cataldo, Maria Letizia
Fu, Xiaoyong
Shea, Martin J.
Mitchell, Tamika
Veeraraghavan, Jamunarani
Nagi, Chandandeep
Pilling, Mark
Rimawi, Mothaffar F.
Trivedi, Meghana
Hilsenbeck, Susan G.
Chamness, Gary C.
Jeselsohn, Rinath
Osborne, C. Kent
Schiff, Rachel
Article History
Received: 25 April 2018
Revised: 5 November 2018
Accepted: 14 November 2018
First Online: 17 December 2018
Competing interests
: R.S. has received research funding (to institution) from AstraZeneca, Gilead, PUMA, and GlaxoSmithKline (GSK). She is a consulting/advisory committee member for Macrogenics, and Eli Lilly. C.K.O. has received research funding from AstraZeneca and GSK. He has been a member of advisory boards for Pfizer, Nanostring, Genentech, Tolmar Pharmaceuticals, and AstraZeneca. He is also a member of a DMC for Eli Lilly. M.F.R. has received research funding (to institution) from Pfizer and GSK. He is a consulting member for Genentech, Novartis, Daiichi Sankyo, and Macrogenics. R.J. received research funding from Pfizer. O.D. is an AstraZeneca employee. H.W., M.P., and H.B. are former AstraZeneca employees.
: All animal care was in accordance with institutional guidelines.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).